[go: up one dir, main page]

ATE509947T1 - Nukleinsäure involviert im responder phenotyp und deren verwendung - Google Patents

Nukleinsäure involviert im responder phenotyp und deren verwendung

Info

Publication number
ATE509947T1
ATE509947T1 AT98961219T AT98961219T ATE509947T1 AT E509947 T1 ATE509947 T1 AT E509947T1 AT 98961219 T AT98961219 T AT 98961219T AT 98961219 T AT98961219 T AT 98961219T AT E509947 T1 ATE509947 T1 AT E509947T1
Authority
AT
Austria
Prior art keywords
nucleic acid
present
acid molecules
relates
recombinant dna
Prior art date
Application number
AT98961219T
Other languages
English (en)
Inventor
Bernhard Herrmann
Birgit Koschorz
Andreas Kispert
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE509947T1 publication Critical patent/ATE509947T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Structures Or Materials For Encapsulating Or Coating Semiconductor Devices Or Solid State Devices (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT98961219T 1997-11-18 1998-11-18 Nukleinsäure involviert im responder phenotyp und deren verwendung ATE509947T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97120190 1997-11-18
EP98103596 1998-03-02
PCT/EP1998/007395 WO1999025815A2 (en) 1997-11-18 1998-11-18 Nucleic acids involved in the responder phenotype and applications thereof

Publications (1)

Publication Number Publication Date
ATE509947T1 true ATE509947T1 (de) 2011-06-15

Family

ID=26145903

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98961219T ATE509947T1 (de) 1997-11-18 1998-11-18 Nukleinsäure involviert im responder phenotyp und deren verwendung

Country Status (7)

Country Link
US (2) US6642369B1 (de)
EP (1) EP1032595B1 (de)
JP (1) JP4749541B2 (de)
AT (1) ATE509947T1 (de)
AU (1) AU1671199A (de)
CA (1) CA2311166C (de)
WO (1) WO1999025815A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9926161D0 (en) * 1999-11-04 2000-01-12 Pig Improvement Company Uk Lim Methods
MXPA02008288A (es) * 2000-02-24 2004-04-05 Univ Massachusetts Prouduccion de mamiferos que producen progenie de un solo sexo.
WO2003064605A2 (en) 2002-01-28 2003-08-07 Ambion, Inc. Crude biological derivatives competent for nucleic acid detection
EP1752040A1 (de) * 2005-08-12 2007-02-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Isolierung eines t-Complex Distorters und dessen Verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
RO114469B1 (ro) 1987-12-15 1999-04-30 Gene Shears Pty Ltd Compus oligoribonucleotidic, procedeu de preparare si metoda de inactivare
CA1340323C (en) 1988-09-20 1999-01-19 Arnold E. Hampel Rna catalyst for cleaving specific rna sequences
CA2120601A1 (en) * 1991-10-04 1993-04-15 Lee M. Silver Sperm surface protein

Also Published As

Publication number Publication date
CA2311166A1 (en) 1999-05-27
WO1999025815A2 (en) 1999-05-27
AU1671199A (en) 1999-06-07
JP2001523449A (ja) 2001-11-27
JP4749541B2 (ja) 2011-08-17
WO1999025815A3 (en) 1999-08-19
EP1032595B1 (de) 2011-05-18
US20040010814A1 (en) 2004-01-15
CA2311166C (en) 2012-06-19
US6642369B1 (en) 2003-11-04
EP1032595A2 (de) 2000-09-06

Similar Documents

Publication Publication Date Title
Pagani et al. Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution
Fadool et al. Transposition of the mariner element from Drosophila mauritiana in zebrafish
Pi et al. Long-range function of an intergenic retrotransposon
ATE198767T1 (de) Hantelförmige expressionskonstrukte für die gentherapie
ATE318900T1 (de) Ef-1-alpha transkriptionsregulatorische dna aus hamster
WO2002000894A3 (en) Gene silencing vector
DE60329220D1 (de) Antisense-entwurf
YU65194A (sh) Promotorni elementi himernih gena za alfa-tubulin
CO5680484A2 (es) Moleculas de ligando gitr y relacionadas con ligando gitr y anticuerpos y usos de estas
ATE404679T1 (de) Neue expressionsvektoren
ATE490321T1 (de) Induzierbare sirna expressionskonstrukte zur gezielten genabschaltung
HK1027375A1 (en) Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna
ATE502043T1 (de) Hochempfindliche polymerasen und ihre verwendungen
WO2000075279A3 (en) Nucleotide sequences for gene regulation and methods of use thereof
ATE509947T1 (de) Nukleinsäure involviert im responder phenotyp und deren verwendung
WO2003048325A3 (en) Nucleotide sequences of shrimp beta-actin and actin promoters and their use in genetic transformation technology
Brehme et al. Mitochondrial RNA editing PPR proteins can tolerate protein tags at E as well as at DYW domain termini
Mondal et al. Advances in animal genomics
DE60130465D1 (de) Mutierte muskelspezifische enhancer
BR0318377A (pt) composições de centrÈmero de planta
MXPA01004353A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
Omachi et al. Comparative analysis and rational design of dCas9-VP64 variants for CRISPR activation
WO2003054217A3 (en) Plant msh2 sequences and methods of use
FR2807064B1 (fr) Gene 763 de champignon phytopatogene et son utilisation pour l'identification de composes fongicides
Xu Studies of mammalian mitochondrial genomes with special emphasis on the Perissodactyla

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties